| Effect of Aspirin on Gut Microbiome (NCT02761486) | University of Minnesota | 2016-08-01 |
| Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection (NCT02852564) | Eugene Lee, MD | 2016-08-01 |
| Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults (NCT02810340) | PATH | 2016-08-01 |
| The Pharmacokinetics, Safety, and Ease of Use of a Portable Metered-Dose Cannabis Inhaler (NCT02729623) | Kite Systems | 2016-08-01 |
| Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis (NCT02866721) | University Hospitals Cleveland Medical Center | 2016-08-01 |
| A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body (NCT03067376) | Corcept Therapeutics | 2016-08-01 |
| Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma (NCT02776813) | Cogent Biosciences, Inc. | 2016-08-01 |
| KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT02867007) | Kyowa Kirin, Inc. | 2016-08-01 |
| Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test (NCT03004339) | DFB Soria, LLC | 2016-08-01 |
| Mass-balance Study of [14C]-APD421 in Healthy Volunteers (NCT02881840) | Acacia Pharma Ltd | 2016-08-01 |
| Panitumumab IRDye800 Optical Imaging Study (NCT02415881) | Eben Rosenthal | 2016-08-01 |
| A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck (NCT02054442) | Radboud University Medical Center | 2016-08-01 |
| A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults (NCT02860650) | Janssen Vaccines & Prevention B.V. | 2016-08-01 |
| GLS-5700 in Dengue Virus Seropositive Adults (NCT02887482) | GeneOne Life Science, Inc. | 2016-08-01 |
| Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors (NCT02857920) | Fuda Cancer Hospital, Guangzhou | 2016-08-01 |
| A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02851095) | Janssen Research & Development, LLC | 2016-08-01 |
| Decitabine and Talazoparib in Untreated AML and R/R AML (NCT02878785) | University of Maryland, Baltimore | 2016-08-01 |
| Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) (NCT02775994) | Rabin Medical Center | 2016-08-01 |
| Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers (NCT02742844) | RHEACELL GmbH & Co. KG | 2016-08-01 |
| A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02846506) | Janssen Research & Development, LLC | 2016-08-01 |
| Sharklet Catheter Study (NCT02669342) | University of British Columbia | 2016-08-01 |
| The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma (NCT03101709) | Henan Cancer Hospital | 2016-08-01 |
| Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer (NCT02862587) | Shanghai International Medical Center | 2016-08-01 |
| A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme (NCT02853565) | CANbridge Life Sciences Ltd. | 2016-08-01 |
| The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users (NCT03264781) | Chulalongkorn University | 2016-08-01 |
| A Study of Mitoxantrone Hydrochloride Liposome Infusion (NCT02856685) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2016-08-01 |
| A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP (NCT02905019) | University of Oxford | 2016-08-01 |
| JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors (NCT02904226) | Jounce Therapeutics, Inc. | 2016-08-01 |
| Mass Balance Study of MT-3995 (NCT02900235) | Tanabe Pharma Corporation | 2016-08-01 |
| Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma (NCT03422874) | Dartmouth-Hitchcock Medical Center | 2016-08-01 |
| Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms (NCT02865538) | Bayer | 2016-08-01 |
| A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects (NCT02859207) | Eisai Inc. | 2016-08-01 |
| Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors (NCT02930993) | China Meitan General Hospital | 2016-08-01 |
| A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer (NCT04147806) | Albert Einstein College of Medicine | 2016-08-01 |
| Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors (NCT02836834) | Shanghai Junshi Bioscience Co., Ltd. | 2016-08-01 |
| Ceftaroline Diffusion Into Cerebrospinal Fluid of Children (NCT02600793) | Basim Asmar | 2016-08-01 |
| Fecal Microbiota Transplantation for Decompensated Cirrhosis (NCT03014505) | First Affiliated Hospital of Chengdu Medical College | 2016-08-01 |
| Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 (NCT02779140) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-01 |
| BE Study in Patients - Methotrexate Tablets (NCT02940561) | Amneal Pharmaceuticals, LLC | 2016-08-01 |
| A Study of ERY974 in Patient With Advanced Solid Tumors (NCT02748837) | Chugai Pharmaceutical | 2016-08-01 |
| A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia (NCT02848248) | Seagen Inc. | 2016-08-01 |
| 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study (NCT02850146) | University of Southern California | 2016-08-01 |
| Effectiveness of Fluoride Varnish in Prevention of Dental Caries in School Children (NCT02877888) | University of Peradeniya | 2016-08-01 |
| A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects (NCT02881294) | Suven Life Sciences Limited | 2016-08-01 |
| Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration (NCT02980458) | SocraTec R&D GmbH | 2016-08-01 |
| A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects (NCT02927353) | Meiji Seika Pharma Co., Ltd. | 2016-08-01 |
| Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age (NCT02919293) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2016-08-01 |
| A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects (NCT03023085) | Braintree Laboratories | 2016-08-01 |
| The Addition of Chloroquine to Chemoradiation for Glioblastoma (NCT02378532) | Maastricht Radiation Oncology | 2016-08-01 |
| Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin (NCT02854748) | Chong Kun Dang Pharmaceutical | 2016-08-01 |
| A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects (NCT03650608) | Hanlim Pharm. Co., Ltd. | 2016-08-01 |
| A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02865668) | Janssen Research & Development, LLC | 2016-08-01 |
| PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (NCT02873390) | Ningbo Cancer Hospital | 2016-08-01 |
| GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals (NCT02584751) | James J. Peters Veterans Affairs Medical Center | 2016-08-01 |
| Infection and Tumour Antigen Cellular Therapy (NCT02895412) | University of Sydney | 2016-08-01 |
| MASCT-I Treatment for Advanced Solid Tumor (NCT02858232) | The First People's Hospital of Lianyungang | 2016-08-01 |
| Impact of Daily Bathing With Chlorhexidine in the Critical Patient (NCT02870062) | Universidad Autonoma de Nuevo Leon | 2016-08-01 |
| Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake (NCT02883166) | Radboud University Medical Center | 2016-08-01 |
| A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers (NCT02873767) | UCB Biopharma S.P.R.L. | 2016-08-01 |
| A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS) (NCT02835794) | University of Florida | 2016-08-01 |
| Does Micropattern on Urinary Catheter Surface Reduce Urinary Tract Infections? (NCT02835456) | Jahn Ferenc South Pest Teaching Hospital | 2016-08-01 |
| Metformin in Breast Cancer, Visualized With Positron Emission Tomography (NCT02882581) | Aarhus University Hospital | 2016-08-01 |
| Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer (NCT02873442) | Ningbo Cancer Hospital | 2016-08-01 |
| A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Participants (NCT02884089) | Eli Lilly and Company | 2016-08-01 |
| To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants (NCT02885454) | Janssen Research & Development, LLC | 2016-08-01 |
| TK216 in Patients With Relapsed or Refractory Ewing Sarcoma (NCT02657005) | Oncternal Therapeutics, Inc | 2016-08-01 |
| Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers (NCT02914262) | Aerpio Therapeutics | 2016-08-01 |
| Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems (NCT03000218) | Seoul National University Hospital | 2016-08-01 |
| A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants (NCT02829541) | Biogen | 2016-08-01 |
| Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT03083054) | University of Campinas, Brazil | 2016-08-01 |
| A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines (NCT02956746) | Synermore Biologics Co., Ltd. | 2016-08-01 |
| Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma (NCT02965157) | Beijing Biohealthcare Biotechnology Co.,Ltd | 2016-08-01 |
| Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response (NCT02823106) | Justin Fraser | 2016-08-01 |
| A Trial of Dextromethorphan for Treatment of Major Depressive Disorder (NCT02860962) | Medical University of South Carolina | 2016-08-01 |
| K1-70 - A Study in Subjects With Graves' Disease (NCT02904330) | AV7 Limited | 2016-08-01 |
| Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia (NCT02746952) | Institut de Recherches Internationales Servier | 2016-08-01 |
| Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer (NCT02862613) | Shanghai International Medical Center | 2016-08-01 |
| A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy (NCT02970474) | Tulane University | 2016-08-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects (NCT02955420) | Berlin Cures GmbH | 2016-08-01 |
| Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT02861040) | Northwestern University | 2016-08-01 |
| Single Ascending Dose Safety Study of Oxfendazole (NCT01584362) | Johns Hopkins Bloomberg School of Public Health | 2016-08-01 |
| Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft (NCT02592330) | Massachusetts Eye and Ear Infirmary | 2016-08-01 |
| Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer (NCT02862561) | Shanghai International Medical Center | 2016-08-01 |
| Evaluation of the Effect of Fluoride and Laser Application on the Prevention of Sensitivity in Bleached Teeth (NCT03044171) | Universidade Federal do Para | 2016-08-01 |
| Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects (NCT03110276) | Enyo Pharma | 2016-08-01 |
| An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study (NCT02884479) | SciClone Pharmaceuticals International (Cayman) Development Limited | 2016-08-01 |
| Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions (NCT02862145) | Mirna Therapeutics, Inc. | 2016-08-01 |
| Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants (NCT02859701) | Allakos Inc. | 2016-08-01 |
| Treatment Outcome in Major Depressive Disorder (NCT02869035) | Rigshospitalet, Denmark | 2016-08-01 |
| Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer (NCT02894944) | Seoul National University Hospital | 2016-08-01 |
| Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer (NCT02708511) | Sanjiv Sam Gambhir | 2016-08-01 |
| Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia (NCT02451371) | Seoul National University Hospital | 2016-08-01 |
| SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence (NCT02830542) | Seres Therapeutics, Inc. | 2016-08-01 |
| Stem Cell Injection in Cancer Survivors (NCT02509156) | The University of Texas Health Science Center, Houston | 2016-08-01 |
| Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans (NCT02789241) | Robert J Noveck, M.D. | 2016-08-01 |
| Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8 (NCT02882217) | EURRUS Biotech GmbH | 2016-08-01 |
| PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants (NCT02831517) | Biogen | 2016-08-01 |
| PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies (NCT02730312) | Xencor, Inc. | 2016-08-01 |
| Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study (NCT02877771) | Tandem Diabetes Care, Inc. | 2016-08-01 |
| Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea (NCT03045926) | Ipsen | 2016-08-01 |